Phosphatase and tensin homolog deleted on chromosome10 (pten) and ph domain and leucine-rich repeat phosphatase cross-talk (phlpp) in cancer cells and in transforming growth factor β-activated stem cells

Journal of Biological Chemistry

Volumn 289, Issue 17, 2014, Pages 11601-11615

  Ghalali, Aram ^a   Ye, Zhi Wei ^a   Högberg, Johan ^a   Stenius, Ulla ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CROSSTALK; DISEASES; STEM CELLS;

CANCER CELLS; GROWTH FACTOR; LEUCINE-RICH REPEATS; PROSTATE CANCER CELLS; TRANSFORMING GROWTH FACTORS; TUMOR DEVELOPMENT;

PHOSPHATASES;

MICRORNA; MICRORNA 190; MICRORNA 214; ONCOPROTEIN; PH DOMAIN AND LEUCINE RICH REPEAT PHOSPHATASE CROSS TALK; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PURINERGIC P2X4 RECEPTOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STEM CELL; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE ACTIVATION; HUMAN; HUMAN CELL; MALE; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RNA SEQUENCE; UPREGULATION;

AKT; PHLPP1; PHLPP2; PROSTATE CANCER; PROTEIN PHOSPHATASE; PTEN; STEM CELLS;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; EPIGENESIS, GENETIC; HUMANS; MALE; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84899459754     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.537241     Document Type: Article

References (57)

1. Salmena, L., Carracedo, A., and Pandolfi, P. P. (2008) Tenets of PTEN tumor suppression. Cell 133, 403-414
2. Cheng, G. Z., Zhang, W., and Wang, L. H. (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res. 68, 957-960
3. Dreesen, O., and Brivanlou, A. H. (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 3, 7-17
4. Lamouille, S., Connolly, E., Smyth, J. W., Akhurst, R. J., and Derynck, R. (2012) TGF-β-induced activation of mTOR complex 2 drives epithelialmesenchymal transition and cell invasion. J. Cell Sci. 125, 1259-1273
5. Mulholland, D. J., Kobayashi, N., Ruscetti, M., Zhi, A., Tran, L. M., Huang, J., Gleave, M., and Wu, H. (2012) Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 72, 1878-1889
6. O'Neill, A. K., Niederst, M. J., and Newton, A. C. (2013) Suppression of survival signalling pathways by the phosphatase PHLPP. FEBS J. 280, 572-583
7. Rabinovsky, R., Pochanard, P., McNear, C., Brachmann, S. M., Duke-Cohan, J. S., Garraway, L. A., and Sellers, W. R. (2009) p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. Mol. Cell Biol. 29, 5377-5388
8. Molina, J. R., Agarwal, N. K., Morales, F. C., Hayashi, Y., Aldape, K. D., Cote, G., and Georgescu, M. M. (2012) PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene 31, 1264-1274
9. Mistafa, O., Ghalali, A., Kadekar, S., Högberg, J., and Stenius, U. (2010) Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. J. Biol. Chem. 285, 27900-27910
10. Bian, S., Sun, X., Bai, A., Zhang, C., Li, L., Enjyoji, K., Junger, W. G., Robson, S. C., and Wu, Y. (2013) P2X7 integrates PI3K/AKT and AMPKPRAS40- mTOR signaling pathways to mediate tumor cell death. PloS One 8, e60184
11. Mulholland, D. J., Tran, L. M., Li, Y., Cai, H., Morim, A., Wang, S., Plaisier, S., Garraway, I. P., Huang, J., Graeber, T. G., and Wu, H. (2011) Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 19, 792-804
12. Chen, M., Pratt, C. P., Zeeman, M. E., Schultz, N., Taylor, B. S., O'Neill, A., Castillo-Martin, M., Nowak, D. G., Naguib, A., Grace, D. M., Murn, J., Navin, N., Atwal, G. S., Sander, C., Gerald, W. L., Cordon-Cardo, C., Newton, A. C., Carver, B. S., and Trotman, L. C. (2011) Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 20, 173-186
13. Idoine, J. B., Elliott, J. M., Wilson, M. J., and Weisburger, E. K. (1976) Rat liver cells in culture: effect of storage, long-term culture, and transformation on some enzyme levels. In Vitro 12, 541-553
14. Al Rashid, S. T., Dellaire, G., Cuddihy, A., Jalali, F., Vaid, M., Coackley, C., Folkard, M., Xu, Y., Chen, B. P., Chen, D. J., Lilge, L., Prise, K. M., Bazett Jones, D. P., and Bristow, R. G. (2005) Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res. 65,10810-10821
15. Liu, B., Wu, X., Liu, B., Wang, C., Liu, Y., Zhou, Q., and Xu, K. (2012) miR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim. Biophys. Acta 1822, 1692-1704
16. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., and Patel, T. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658
17. Yang, H., Kong, W., He, L., Zhao, J. J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., and Cheng, J. Q. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 inducescell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433
18. Beezhold, K., Liu, J., Kan, H., Meighan, T., Castranova, V., Shi, X., and Chen, F. (2011) miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol. Sci. 123, 411-420
19. Jindra, P. T., Bagley, J., Godwin, J. G., and Iacomini, J. (2010) Costimulation- dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J. Immunol. 185, 990-997
20. Li, L. M., Hou, D. X., Guo, Y. L., Yang, J. W., Liu, Y., Zhang, C. Y., and Zen, K. (2011) Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in mono- cytes. J. Immunol. 186, 2552-2560
21. Odriozola, L., Singh, G., Hoang, T., and Chan, A. M. (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282, 23306-23315
22. Fan, C., He, L., Kapoor, A., Rybak, A. P., De Melo, J., Cutz, J. C., and Tang, D. (2009) PTEN inhibits BMI1 function independently of its phosphatase activity. Mol. Cancer 8, 98
23. Juan, A. H., Kumar, R. M., Marx, J. G., Young, R. A., and Sartorelli, V. (2009) miR-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 36, 61-74
24. Yoshimi, A., and Kurokawa, M. (2011) Evi1 forms a bridge between the epigenetic machinery and signaling pathways. Oncotarget. 2, 575-586
25. Lukacs, R. U., Memarzadeh, S., Wu, H., and Witte, O. N. (2010) Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7, 682-693
26. Yoshimi, A., Goyama, S., Watanabe-Okochi, N., Yoshiki, Y., Nannya, Y., Nitta, E., Arai, S., Sato, T., Shimabe, M., Nakagawa, M., Imai, Y., Kitamura, T., and Kurokawa, M. (2011) Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. Blood 117, 3617-3628
27. Samudio-Ruiz, S. L., and Hudson, L. G. (2012) Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells. Epigenetics 7, 216-224
28. Leslie, N. R., Yang, X., Downes, C. P., and Weijer, C. J. (2007) PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr. Biol. 17, 115-125
29. Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N. S., Jackson, K. W., Suri, P., and Wicha, M. S. (2006) Hedgehog signaling and Bmi-1 regulate selfrenewal of normal and malignant human mammary stem cells. CancerRes. 66, 6063-6071
30. Molofsky, A. V., Pardal, R., Iwashita, T., Park, I. K., Clarke, M. F., and Morrison, S. J. (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967
31. Park, I. K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., and Clarke, M. F. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305
32. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890
33. Yang, G., Quan, Y., Wang, W., Fu, Q., Wu, J., Mei, T., Li, J., Tang, Y., Luo, C., Ouyang, Q., Chen, S., Wu, L., Hei, T. K., and Wang, Y. (2012) Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br. J. Cancer 106,1512-1519
34. MassaguéJ., J. (2008) TGFβ in cancer. Cell 134, 215-230
35. Lou, C., Zhang, F., Yang, M., Zhao, J., Zeng, W., Fang, X., Zhang, Y., Zhang, C., and Liang, W. (2012) Naringenin decreases invasiveness and metastasis by inhibiting TGF-β -induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS One 7, e50956
36. Fuxe, J., and Karlsson, M. C. (2012) TGF-β -induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin. Cancer Biol. 22, 455-461
37. Shukla, S., Maclennan, G. T., Hartman, D. J., Fu, P., Resnick, M. I., and Gupta, S. (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int. J. Cancer 121, 1424-1432
38. Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella-Abate, S., De Pittà, C., Pinatel, E., Stadler, M. B., Provero, P., Bernengo, M. G., Osman, I., and Taverna, D. (2011) MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 30, 1990-2007
39. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257-2261
40. Jiang, L. H., Mackenzie, A. B., North, R. A., and Surprenant, A. (2000) Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol. Pharmacol. 58, 82-88
41. Weinhold, K., Krause-Buchholz, U., Rödel, G., Kasper, M., and Barth, K. (2010) Interaction and interrelation of P2X7 and P2X4 receptor complexes in mouse lung epithelial cells. Cell Mol. Life Sci. 67, 2631-2642
42. Bradley, E. W., Carpio, L. R., and Westendorf, J. J. (2013) Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (PHLPP)1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J. Biol. Chem. 288, 9572-9582
43. Shiota, M., Zardan, A., Takeuchi, A., Kumano, M., Beraldi, E., Naito, S., Zoubeidi, A., and Gleave, M. E. (2012) Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Res. 72, 5261-5272
44. Glass, R., Loesch, A., Bodin, P., and Burnstock, G. (2002) P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell Mol. Life Sci. 59, 870-881
45. Zippel, N., Limbach, C. A., Ratajski, N., Urban, C., Luparello, C., Pansky, A., Kassack, M. U., and Tobiasch, E. (2012) Purinergic receptors influence the differentiation of human mesenchymal stem cells. Stem Cells Dev. 21, 884-900
46. Freeman, K. W., Bowman, B. R., and Zetter, B. R. (2011) Regenerative protein thymosin β-4 is a novel regulator of purinergic signaling. FASEB J. 25, 907-915
47. Silins, I., Högberg, J., and Stenius, U. (2006) Dietary sphingolipids suppress a subset of preneoplastic rat liver lesions exhibiting high PTEN, low phospho- Akt and high levels of ceramide species. Food Chem. Toxicol. 44, 1552-1561
48. Takahashi, M., Shibutani, M., Woo, G. H., Inoue, K., Fujimoto, H., Igarashi, K., Kanno, J., Hirose, M., and Nishikawa, A. (2008) Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model. Carcinogenesis 29, 2218-2226
49. Sell, S., and Leffert, H. L. (2008) Liver cancer stem cells. J. Clin. Oncol. 26, 2800-2805
50. Davies, M. A., Kim, S. J., Parikh, N. U., Dong, Z., Bucana, C. D., and Gallick, G. E. (2002) Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res. 8, 1904-1914
51. Fenouille, N., Tichet, M., Dufies, M., Pottier, A., Mogha, A., Soo, J. K., Rocchi, S., Mallavialle, A., Galibert, M. D., Khammari, A., Lacour, J. P., Ballotti, R., Deckert, M., and Tartare-Deckert, S. (2012) The epithelialmesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.PLoS One 7, e40378
52. Xue, G., Restuccia, D. F., Lan, Q., Hynx, D., Dirnhofer, S., Hess, D., Rüegg, C., and Hemmings, B. A. (2012) Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-βsignaling axes. Cancer Discov. 2, 248-259
53. Costello, J. C., Rosenthal, A. K., Kurup, I. V., Masuda, I., Medhora, M., and Ryan, L. M. (2011) Parallel regulation of extracellular ATP and inorganic pyrophosphate: roles of growth factors, transduction modulators, and ANK. Connect Tissue Res. 52, 139-146
54. Deal, F. H., Richardson, F. C., and Swenberg, J. A. (1989) Dose response of hepatocyte replication in rats following continuous exposure to diethylnitrosamine. Cancer Res. 49, 6985-6988
55. +microglia drive neuropathic pain. Nat. Neurosci. 15, 1068-1073
56. Tenbaum, S. P., Ordóñez-Morán, P., Puig, I., Chicote, I., Arqués, O., Landolfi, S., Fernández, Y., Herance, J. R., Gispert, J. D., Mendizabal, L., Aguilar, S., Ramón y Cajal, S., Schwartz, S., Jr., Vivancos, A., Espín, E., Rojas, S., Baselga, J., Tabernero, J., Muñoz, A., and Palmer, H. G. (2012) β-Catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat. Med. 18, 892-901
57. Peltier, H. J., and Latham, G. J. (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14,844-852